NCT01540461 2014-07-08Determine the Pharmacokinetics and Safety of Brivanib in Chinese Subjects With Advanced Primary Liver Cancer (Hepatocellular Carcinoma: HCC)Bristol-Myers SquibbPhase 1 Completed17 enrolled
NCT00437424 2011-05-04A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver DysfunctionBristol-Myers SquibbPhase 1 Completed24 enrolled